Protocol No.: WVU010922

Prospective Evaluation of Xerava (Eravacycline) Prophylaxis in Hematological Malignancy Patients with Prolonged Neutropenia
Principal Investigator
Cumpston, Aaron
Phase
II
Age Group
Adult
Applicable Disease Site
Leukemia
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Kristin Volk, RN
Research Nurse
Phone: +1 304-581-1893

View on ClinicalTrials.gov